|
235 First
pharmacist prescribers registered by Society Fourteen pharmacists
were registered as supplementary prescribers this week by the Royal Pharmaceutical
Society ...more
235 AAH
welcomes contract delay as opportunity to iron out difficulties Delaying implementation of the new pharmacy contract for England and Wales until October has been welcomed by AAH Pharmaceuticals as “a much-needed opportunity to iron out numerous imponderables”
...more
235 Summary
judgment applied for in SOS case The 17 defendants involved
in the legal action taken by the four claimants representing the Save
Our Society group filed their defence this week. They have made an application
for summary judgment ...more
235 Wanless
report The second Wanless report on public health was published
on 25 February, as The Journal went to press ...more
236 Priority
action points spelt out for pharmacy in Wales Plans for the implementation of the strategy for pharmacy in Wales “Remedies for success” have been produced by the Welsh Assembly Government
...more
236 BT
wins NHS contract for broadband network A contract to provide and manage a broadband network — known as N3 (new national network) — to link all NHS organisations in England has been awarded to BT. The position of community pharmacies in the contract is unclear
...more
237 National
Reporting and Learning System launched The National Reporting
and Learning System (NRLS) developed by the National Patient Safety Agency
was launched this week in England and Wales ...more
237 Pharmacists
should have input into design of new drug packaging Pharmacists’ and patients’ opinions should be central to the design of new drug packaging and labelling, according to Peter Buckle, director of the Robens Centre for Health Ergonomics, University of Surrey, and one of the authors of a new safety report published by the Department of Health and the Design Council
...more
237 New
tool to reduce dispensing errors in the pharmacy A new tool
to reduce dispensing errors and allow detection of counterfeit products
could be in pharmacies within the next year, according to PA Consulting
Group ...more
237 Thrombolytics
after heart attack Since publication of the National Service
Framework for Coronary Heart Disease in 2000, the number of patients
receiving early thrombolysis after a heart attack has more than doubled
...more
|
237 Use 2222
as crash call number The telephone number used within hospitals
to summon emergency care staff to patients suffering a cardiac arrest
should be standardised, says the National Patient Safety Agency ...more
238 Patients
not ready for home BP or INR monitoring Antihypertensive treatment
that is adjusted according to blood pressure measurements made by patients
themselves provides less long-term control than treatment adjusted according
to measurements made at a clinic, say Irish and Belgian researchers ...more
238 Government
looks at instalment dispensing for benzodiazepines Instalment
dispensing for benzodiazepines is likely to be introduced within the
year, the Department of Health confirmed this week ...more
238 Alliance-UniChem
reports surge in profits Alliance-UniChem has reported 16
per cent growth in pre-tax operating profit for the year to 31 December
2003. Actual profit was £263.4m on turnover of £8,799.3m
(up 13 per cent) ...more
238 Technicians'
concerns heard Concerns raised earlier this month about pharmacy
technicians participating in Agenda for Change have been clearly recognised
and understood, according to the Association of Pharmacy Technicians
UK and UNISON ...more
239 NICE issues
guideline for management of COPD A guideline for the management
of chronic obstructive pulmonary disease has been issued by the National
Institute for Clinical Excellence and the National Collaborating Centre
for Chronic Conditions ...more
239 Guidance
sets out advice for couples with fertility problems Advice
that should be offered to couples with fertility problems has been set
out by the National Institute for Clinical Excellence this week ...more
239 Asthma, but
not COPD, associated with use of hormone therapy Use of hormone
replacement therapy by postmenopausal women is associated with an increased
incidence of newly diagnosed asthma but not chronic obstructive pulmonary
disease, say US researchers. Previous studies have suggested that changes
in reproductive hormones may influence the development of asthma and
asthma severity ...more
|
The
Pharmaceutical Journal